Product logins

Find logins to all Clarivate products below.


chevron_left

Thinking of Zebras

Consulting Resource Center
Thinking of Zebras

Delivering innovative medicines to patients with rare diseases

Taking a patient-centered approach to drug development and commercialization is nowhere more critical than when working in the rare disease space. Every patient’s condition and circumstances are unique, and patients with a rare disease are typically navigating a bewildering array of providers, institutions and, in some cases, payers in order to manage their complex disease. Moreover, developing treatments for these diseases can be resource intensive, and each patient is essential to the commercial viability of these endeavors.

Read our eBook to learn how companies can deliver on their promises and help ensure that when we hear hoofbeats, we think of zebras as well as horses by fully embracing a rare disease mindset from:

  • Recognizing zebras along the patient journey
  • Considering zebras from strategy to execution
  • Reflecting zebras from insight to impact

Related insights

The latest news, technologies, and resources from our team.

Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
The market access “sweet spots” where payers reimburse more convenient therapies The market access “sweet spots” where payers reimburse more convenient therapies
Blog February 19, 2026
The market access “sweet spots” where payers reimburse more convenient therapies
chevron_left
chevron_right